<p>The present invention provides novel mGlu2 agonists useful in the treatment of bipolar disorder, schizophrenia, depression, and generalized anxiety disorder.</p>
申请公布号
SI2516406(T1)
申请公布日期
2013.11.29
申请号
SI20100030387T
申请日期
2010.12.15
申请人
ELI LILLY AND COMPANY
发明人
MONN JAMES ALLEN;PRIETO LOURDES;TABOADA MARTINEZ LORENA;MONTERO SALGADO CARLOS;SHAW BRUCE WILLIAM
